Workflow
Sonos outlines $12B expansion opportunity and new strategy while reducing operating expenses by over $100M (NASDAQ:SONO)
Seeking Alpha· 2025-11-05 22:02
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Eastern Company signals cautious recovery outlook as restructuring and cost actions offset end-market headwinds (NASDAQ:EML)
Seeking Alpha· 2025-11-05 22:02
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Energy Transfer LP Common Units 2025 Q3 - Results - Earnings Call Presentation (NYSE:ET) 2025-11-05
Seeking Alpha· 2025-11-05 22:02
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
AMD: Caught In A Back-To-The-Future Situation (NASDAQ:AMD)
Seeking Alpha· 2025-11-05 22:02
Don’t just invest—dominate with Tech Contrarians' realized return on closed positions of 65.8% since inception. You’ll get exclusive insights into high-focus stocks, curated watchlists, one-on-one portfolio consultations, and everything from live portfolio tracking to earnings updates on 50+ companies. Subscribe today for 20% off.Advanced Micro Devices, Inc. ( AMD ) reported its Q3 results after the bell on Tuesday. If anyone was on that earnings call , you would’ve noticed that management dodged all analys ...
Rayonier Advanced Materials targets over $300M EBITDA by 2027 amid cost discipline and capacity resets (NYSE:RYAM)
Seeking Alpha· 2025-11-05 22:02
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Kinaxis Inc. Reports Third Quarter 2025 Results
Businesswire· 2025-11-05 22:02
Core Insights - Kinaxis Inc. reported strong third-quarter results for 2025, with total revenue reaching $134.6 million, an 11% increase from $121.5 million in Q3 2024 [3][22] - The company experienced significant growth in its Annual Recurring Revenue (ARR), which rose to $407 million, reflecting a 17% increase year-over-year [4][5] - The launch of AI-powered Maestro Agents is expected to create new revenue streams and enhance customer productivity, with one early adopter reporting a tenfold increase in planner productivity [2][29] Financial Performance - Total revenue for Q3 2025 was $134,592 thousand, compared to $121,528 thousand in Q3 2024, marking an 11% increase [3] - SaaS revenue grew by 17% to $91,955 thousand from $78,621 thousand in the previous year [3] - Gross profit increased to $85,949 thousand, with a gross margin of 64%, up from 63% in Q3 2024 [3] - Profit for the quarter was $16,846 thousand, a 150% increase from $6,751 thousand in Q3 2024 [3][22] - Adjusted EBITDA reached $33,922 thousand, maintaining a margin of 25% [3] Key Performance Indicators - ARR at the end of Q3 2025 was $407 million, reflecting a 17% growth compared to $347 million in Q3 2024 [4][5] - The company expects to recognize future revenue of $846.1 million from unsatisfied performance obligations as of September 30, 2025 [6][7] Financial Guidance - Kinaxis updated its fiscal 2025 guidance, projecting total revenue between $535 million and $550 million, with SaaS revenue growth expected at 15-17% [10] - The company anticipates an Adjusted EBITDA margin of 24-26% for the fiscal year [10] Strategic Initiatives - The introduction of Maestro Agents is a significant step towards enhancing supply chain orchestration capabilities, aimed at improving customer outcomes and creating new revenue opportunities [2][29] - The company is focused on converting on-premise business to SaaS to leverage innovations available in cloud environments [10]
AMD: Caught In A Back-To-The-Future Situation
Seeking Alpha· 2025-11-05 22:02
Don’t just invest—dominate with Tech Contrarians' realized return on closed positions of 65.8% since inception. You’ll get exclusive insights into high-focus stocks, curated watchlists, one-on-one portfolio consultations, and everything from live portfolio tracking to earnings updates on 50+ companies. Subscribe today for 20% off.Advanced Micro Devices, Inc. ( AMD ) reported its Q3 results after the bell on Tuesday. If anyone was on that earnings call , you would’ve noticed that management dodged all analys ...
Pfizer preparing to raise its bid for Metsera, WSJ reports
Reuters· 2025-11-05 22:02
Pfizer is preparing to sweeten its offer again for Metsera , the Wall Street Journal reported on Wednesday, citing people familiar with the matter. ...
Sun Life increases Common Share dividend and declares dividends on Preferred Shares payable in Q4 2025
Prnewswire· 2025-11-05 22:02
Accessibility StatementSkip Navigation TORONTO, Nov. 5, 2025 /PRNewswire/ -Â The Board of Directors ("the Board") of Sun Life Financial Inc. ("the Company") (TSX: SLF) (NYSE: SLF) today announced that a dividend of $0.92 per share on the common shares of the Company has been declared, payable December 31, 2025 to shareholders of record at the close of business on November 26, 2025. This represents a 4 cent increase to the amount paid in the previous quarter. The Board also announced that the following divid ...
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
Accessnewswire· 2025-11-05 22:02
Contact Us Back to the Newsroom ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025 Presenting on Wednesday, December 3, 2025 Members of the ClearPoint Neuro management team will be onsite and available for in-person investor meetings who are registered to attend the various conferences. Topic:Â Conferences SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 5, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene t ...